⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL264100 | 0.67 | — | — | |
| SCHEMBL630634 | 0.65 | HDAC6 (0.41) | — | |
| SCHEMBL30659527 | 0.62 | — | — | |
| Hydrochloric Acid SCHEMBL7988951 | 0.62 | HDAC6 (0.40) | — | |
| SCHEMBL1338506 | 0.61 | — | — | |
| SCHEMBL3060846 | 0.61 | HDAC8 (0.37) | — | |
| SCHEMBL4263883 | 0.61 | — | — | |
| SCHEMBL6820045 | 0.61 | CYP1A2 (0.46) | — | |
| SCHEMBL5722550 | 0.60 | — | — | |
| SCHEMBL47202 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2271 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117069063-A | Sodium hydride suspension and application thereof in flow chemical reaction | 武汉药明康德新药开发有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-114471412-B | Preparation method of substituted pyridopyrrole compound | 上海罕道医药科技有限公司 | 2023-09-26 | — | — | CN | claimed |
| CN-112964881-B | High-throughput high-sensitivity single cell transfection protein analysis chip | 上海交通大学 | 2022-12-06 | — | — | CN | claimed |
| CN-114573578-A | Preparation method of alkyl substituted azaindole | 烟台宁远药业有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114471412-A | Preparation method of substituted pyridopyrrole compound | 上海罕道医药科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-112964881-A | High-throughput high-sensitivity single cell transfection protein analysis chip | 上海交通大学 | 2021-06-15 | — | — | CN | claimed |
| US-11013250-B2 | Methods and compositions for consumables | IMPOSSIBLE FOODS INC. (US) | 2021-05-25 | — | — | US | claimed |
| US-10993462-B2 | Methods and compositions for consumables | IMPOSSIBLE FOODS INC. (US) | 2021-05-04 | — | — | US | claimed |
| US-20190200658-A1 | METHODS AND COMPOSITIONS FOR CONSUMABLES | IMPOSSIBLE FOODS INC. | 2019-07-04 | — | — | US | claimed |
| US-20190116855-A1 | METHODS AND COMPOSITIONS FOR CONSUMABLES | IMPOSSIBLE FOODS INC. | 2019-04-25 | — | — | US | claimed |
| EP-3805236-B1 | FLUORESCENT COMPOUND AND FLUORESCENT LABELED BIOLOGICAL SUBSTANCE USING THE SAME | FUJIFILM CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20250262144-A1 | Deodorant | Java Beard, LLC | 2025-08-21 | — | — | US | disclosed |
| US-20250188055-A1 | Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer | UNITY BIOTECHNOLOGY, INC. | 2025-06-12 | — | — | US | disclosed |
| US-20250172566-A1 | SACCHARIDE SENSING SYSTEMS | Carbometrics Limited (GB) | 2025-05-29 | — | — | US | disclosed |
| US-12221433-B2 | Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer | UNITY BIOTECHNOLOGY, INC. (US) | 2025-02-11 | — | — | US | disclosed |
| WO-2003035057-A1 | INHIBITORS OF DIPEPTIDYL PEPTIDASE IV | FERRING B.V. (NL) | 2003-05-01 | — | — | WO | disclosed |
| WO-2003016316-A1 | DIAZACYCLOALKANES AS OXYTOCIN AGONISTS | FERRING B.V. (NL) | 2003-02-27 | — | — | WO | disclosed |
| US-6350733-B1 | 4-HYDROXYBENZOPYRAN-2-ONE DERIVATIVES; BACTERICIDES FOR STAPHYLOCOCCUS INFECTIONS; SKIN DISORDERS | AVENTIS PHARMA S.A. (FR) | 2002-02-26 | — | — | US | disclosed |
| US-20020010322-A1 | New aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments | AVENTIS PHARMA S.A. | 2002-01-24 | — | — | US | disclosed |
| EP-0906326-B1 | NOVEL AROMATIC DERIVATIVES SUBSTITUTED BY A RIBOSE, THEIR METHOD OF PREPARATION AND APPLICATION AS MEDICINE | AVENTIS PHARMA SA (FR) | 2001-11-21 | — | — | EP | disclosed |